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ABSTRACT
Biological functions of folic acid (FA) have 
been reported in various cells to include syn-
thesis and repair of DNA. We have shown that 
over-dosage of FA causes blood haemolysis, 
leading to progressive anaemia. It is reported 
that 200 – 400 µg/ml of FA increases the size 
of blood cells within 2h of treatment leading 
to abnormal cell division and necrosis. This 
observation suggests early cellular aging or 
senescence. We hypothesized that FA may play 
a vital role in cellular senescence. Kidney fibro-
blast (cos7) cells were treated with 200 µg of FA 
in combination with an anti-neoplastic agent, 
nocodazole prior to FA treatment. FA affected 
the expression of fibronectin (protein marker 
for aging) after nocodazole exposure. Further-
more, fibronectin expression was higher in FA-
treated cells of the 14th generation compared 
to the 8th generation. 14th generation cells also 
showed a decrease in cell size when exposed 
to FA treatment. Contrasting previous results, 
treating cancer cells with FA showed in fact 
cell-beneficial effects as FA over-dosage has a 
noticeable effect on cell aging. However, these 
effects may be cell type or tissue-specific.
INTRODUCTION
The significance of folic acid (FA) in biologi-cal functions like biosynthesis of nucleo-
tides and re-methylation of homocysteine, and 
synthesis of DNA and its repair has been re-
ported in many cell types. Studies have shown 
that folic acid acts as a co-factor, and helps in 
cell division and growth (Wikipedia). Folate 
deficiency is correlated to serious health prob-
lems including neural tube defects in develop-
ing embryos (Wolff & others, 2009). Therefore 
women consume FA during early stages of 
pregnancy. FA also helps in the production of 
red and white blood cells, and its deficiency 
may lead to anemia, leading to fatigue, weak-
ness and inability to concentrate (Zalusky & 
Herbert, 1961).  
 In the field of aging FA is a largely 
debated topic. While many articles and health 
websites suggest FA supplements to decrease 
the rate of aging, several researchers believe 
FA plays detrimental roles in the health of 
certain patients. Canada, the USA, and many 
other nations currently fortify foods such as 
wheat and cereals with FA. It is also a readily 
available over-the counter drug. Therefore the 
uncontrolled/unaccounted consumption of FA 
is increasing day by day. 
 We previously observed that FA over 
dosage causes blood haemolysis, a positive 
sign for progressive anaemia. 200– 400μg/ml 
of FA caused an abnormal blood cell division 
and necrosis suggesting early cellular aging 
or senescence. Cells derived from embryonic 
RÉSUMÉ
L’espèce copépode, Tigriopus californicus, est 
une des espèces les plus thermiquement adapt-
ables de la biosphère. On les trouve dans les 
bâches depuis la côte de l’Alaska jusqu’à la côte 
sud de la Californie. 
 Toutefois, comme tous les autres organ-
ismes, les Tigriopus californicus ont des limites 
et ne peuvent pas tolérer des températures 
supérieures à 34oC. En comparant l’expression 
génétique entre les spécimens exposés à des 
températures élevées et ceux exposés à des 
températures optimales, nous avons identifié 
les gènes responsables de la tolérance à des 
températures en hausse. Après avoir testé 
l’expression génétique entre les copépodes à 
20oC et à 34oC, nous avons déterminé que le 
gène hsp70 et les récepteurs de type Toll du T. 
californicus jouent tous deux un rôle dans la 
tolérance aux variations de température.
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tissues can only divide to a finite number of 
times known as the Hayflick limit (Hayflick & 
Moorhead,1961). After amount of cell divisions 
growth arrests and the cells may or may not die 
(reviewed in Hayflick, 1985; Hayflick, 1994). As 
cells approach this limit in cell divisions they 
accumulate fibrous proteins like fibronectin 
(Kumazaki et al., 1991;Dumont et al., 2000).
 I hypothesize that FA plays a vital role 
in cellular senescence. In order to investigate 
this viability, morphology and senescence of 
kidney fibroblast cells (cos-7) will be compared 
to cells exposed to an anti-neoplastic agent, FA 
and a combination of the two. Similar experi-
ments will be conducted with cos-7 cells from 
two different generations, P8 and P14.
RESULTS
FA rescues cells from nocodazole-induced cell 
death process and drives cellular senescence: 
FA treatment caused only minimal changes in 
the cell viability compared to untreated cos-7 
cells Addition of nocodazole and FA, it seemed 
to rescue the cells from the damaging effects 
of the anti-neoplastic agent and increased cell 
viability (Fig. 1). Dramatic changes in cell sizes 
occurred with FA treatment. In both the natu-
rally growing and nocodazole-treated cells, FA 
treatment caused large increase in cell sizes. 
A more prominently effect was observed in 
nocodazole-treated cells (Fig 2). FA supplemen-
tation increased the fibronectin expression in 
both the naturally growing and nocodazole-
treated cos-7 cells. Combined these results 
possibly represents a phase in the cell growth 
where cells undergo proliferation, but are also 
steered towards aging (Fig. 3)
 Older generations show a larger in-
crease in FA induced expression of fibronectin: 
Compared to naturally aging cells of gen-
erations P8 and P14, FA treatments promotes 
increased cell aging. FA treatment did not have 
any significant effects on the cell viability of the 
generations (Fig. 4), although it has significant 
effects on the cell sizes. FA reduced cell sizes 
in both generations with a larger effect shown 
on the P14 cells (Fig. 5). Similarly, FA treatment 
increased the firbronectin expressions in both 
the P8 and P14 cells a marker of cellular senes-
Figure 1  Cell viability was tested using the "Try-
pan Blue Assay". Cells were stained with TBD and 
viewed under a light microscope. The cells with blue 
colour were considered as dead cells while unstained 
cells were considered live cells. Under normal condi-
tions, FA individually caused only minimal changes 
in the cell viability of the naturally growing Cos-7 
cells (This could be due to specific experimental con-
ditions or due to the cell type itself.), although when 
induced with nocodazole, it seemed to rescue the 
cells from the damaging effects of the anti-neoplastic 
agent and increased cell viability.
Figure 2  Cells were stained with Haematoxylin 
and Eosin (H&E) dye for a further clearer image 
and cells were viewed under a light microscope and 
monitored. Pictures were captured at each time 
point for an individual dose using a camera at-
tached to the microscope. Pictures taken were then 
measured digitally using Image-J Computer Soft-
ware. Dramatic changes in cell sizes occurred due 
to FA treatment. In both the naturally growing and 
nocodazole-induced cells, FA treatment caused large 
increase in cell sizes, more prominently affecting the 
nocodazole-induced cells.
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cence. The trend was again greater in the P14 
cells. (Fig. 6) This suggests that FA has a nega-
tive impact on both young and older genera-
tions of cells, but its impacts on older genera-
tions are far more damaging and drastic.
DISCUSSION
FA is a common dietary supplement consumed 
by many people around the world. Although 
widely debated, many nations including 
Canada and the US are currently fortifying 
foods such as wheat and cereals with FA. Due 
to opinions in various media sources many in-
dividuals consume FA as an additional dietary 
supplement in the belief that it reduces the cell 
aging process. Consumption of FA is increasing 
in unprecedented levels with limited research 
into negative side-effects. We have demon-
strated the harmful effects of FA over-dosage 
(200µg-800µg) on blood cells. These current 
findings suggest that FA plays a large role 
in cell senescence process- but its effects are 
dependent on type of senescence (natural vs. 
induced) and cell type. FA should therefore be 
carefully administered depending on the health 
status of an individual. 
FUTURE DIRECTIONS
FA is a drug that may have cell specific effects. 
Therefore I want to test the affects of FA on 
various cell types. It has been suggested that 
FA is beneficial for cancer patients due to its 
cell proliferative properties. A recent study 
illustrated FA’s affects on apoptosis of epithe-
lial cells in the gastric cancer patients (Cao & 
others, 2005). FA is often recommended and 
prescribed in cancer-like disease cases to help 
support a patient’s red blood cell production. 
However, FA over-dose can have deleterious ef-
fects in certain cancers suggesting a dual role in 
cancer-protection against tumor initiation and 
progression of pre-neoplastic cells (Smith et 
al., 2008). Future studies will investigate these 
specific issues. 
MATERIALS AND METHODS
Cells were cultured through standard protocols 
until enough cells were obtained to perform 
viable tests. Equal amounts of cell suspension 
Figure 3  Cell aging was monitored using an as-
say known as the "Dot-blot Assay". FA treatment 
increased the fibronectin expression in both the 
naturally growing and nocogazole-induced Cos-7 
cells prominently, evidently, increasing cell aging. 
This appears to represent a phase in the cell growth 
process where cells undergo proliferation, but are 
also steered towards aging.
Figure 4  FA treatment didn't have any significant 
effects on the cell viability of the generations, al-
though it had a drastic effect on the cell sizes which 
could be due to specific experimental conditions or 
due to the cell types itself.
Figure 5  FA treatment reduced cell sizes in both 
the P8 and P14 cells, although caused a more rapid 
and larger effect on the P14 cells indicating a more 
prominent effect on cells of older generations.
Canadian Young Scientist Journal • La Revue Canadienne de Jeunes Scientifiques #3.2014 
62
1 x 106 cells/well were used during each test. 
Cells were then treated with either 200 μg/ml 
FA in buffered saline (pH 7.2) and/or 100µg/
ml nocodazole. All experiments were carried 
out in triplicates.
Cell Viability
Cells were stained with trypan blue dye and 
viewed under a light microscope. Blue co-
loured cells were considered as dead cells, 
while unstained cells alive. 
Cell Morphology
Cells were additionally stained for a to visual-
ize cell morphology under a light microscope. 
Pictures were captured using a camera attached 
to the microscope and analyzed using Image-J. 
Cell Senescence
Protein samples were distributed on nitro-
cellulose paper and blocked with 5% skimmed 
milk resuspended in 15ml phosphate buffered 
saline-tween 20 (PBS-T). The blot was washed 
3 times with PBS-T and treated with primary 
antibodies specific for fibronectin. A secondary 
antibody that recognizes the primary antibody 
was used to visually detect fibronectin via che-
miluminescence. Photos were analyzed with 
Image-J.
Figure 6  FA treatment increased the firbronectin 
expressions in both the P8 and P14 cells, indicat-
ing clear signs of senescence, although the P14 cells 
had a much more prominent and rapid effect. This 
again indicates that FA has a negative impact on 
both young and older generations of cells, but its 
impacts on older generations are far more damaging 
and drastic.
ABBREVIATIONS
DNA  Deoxyribonucleic acid
UV  Ultra Violet
FA  Folic Acid
PBS-T  Phosphate Buffer Saline - Tween 20
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REVIEW OF "THE EFFECTS OF FOLIC
ACID ON CELLULAR SENESCENCE"
Reviewed by: Shobha Ramsubir, PhD 
Senior Manager, Business Development &
Research, Ontario Genomics Institute
Overview
The study aims to examine the cellular effect 
of over-doses of folic acid (FA) with respect to 
aging. COS-7 cells were treated with FA and the 
effects on cell viability, morphology and fibro-
nectin expression were assessed. The author 
hypothesized that FA plays a role in senescence 
and concluded that FA promotes senescence. 
In the literature, senescence is defined as the 
irreversible loss of cell division capability for 
a cell. Some of the common methods used to 
assess senescence are telomere length assess-
ment, DNA synthesis assays or examination 
of biomarkers such as Ki67/PCNA. One of the 
best characterized methods is the use of the 
β-galactosidase (β-Gal) assay as senescent cells 
have been shown to over-express β-Gal. The 
use of the latter assay would have strengthened 
this study. It was good that the author attempt-
ed to look at different generations of cells for 
this study.
 The article contains numerous gram-
matical, spelling and punctuation errors that 
need to be corrected to make it publication-
ready. The writing also needs to be strength-
ened as at times it is unclear what the author 
us trying to communicate eg. “A recent study 
illustrated FA’s affects on apoptosis of epithe-
lial cells in the gastric cancer patients (Cao & 
others, 2005).” The effect demonstrated is not 
given and so this does not help build evidence 
for the point it is supporting. Some sentences 
throughout should be re-written to be more 
direct.
Abstract
The hypothesis is clearly stated but the abstract 
does not frame the rationale for the study. The 
rest of the paper relates the importance of the 
study to the fact that FA is widely prescribed 
with unknown effects but this is not introduced 
here. 200-400 ug/ml of FA was mentioned but 
it was unclear if these were in vitro or in vivo 
levels. It is mentioned that the function of FA 
varies by cell type but no indication is given as 
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to the choice of COS-7 as model cell line and 
what the normal effects are in this cell type. The 
abstract should summarize the results concisely 
but are more general statements that an effect 
was observed. It should be re-positioned to say 
what this effect was (increase or decrease in a 
particular factor examined). 
Introduction
This section better frames the study. The refer-
ence to Wikipedia should be replaced with a 
reference from the primary literature and other 
data introduced are not referenced at all. This 
would be a good opportunity to expand on the 
pleiotropic effects that are alluded to in various 
sections but not really clarified. 
Results
In general, all bar charts should have error bars 
and some basic statistical analysis performed 
that report the number of replicates.
The discussion of the figures remains general 
and do not describe the data in depth as one 
would expect in this section. Figures with mul-
tiple images should be labelled as “(a)”, “(b)” 
etc and each image discussed. 
Fig 1-3. What generation of cells were used for 
this assay? 
Fig 2. “Dramatic changes in cell size” is re-
ported in response to addition of FA. In Fig 1 it 
suggests that FA rescues cells from the effect of 
nocodazole but this is not reflected in Fig 3.
Fig 3. The dot-blot assay is not really discussed 
in the results section or the figure title. 
Fig 4. Title refers to cell size data but none is 
shown in this figure. 
Fig 5. The figure mentions a more “rapid” effect 
on P14 cells but time data is not shown or dis-
cussed. It is not clear what arrows in the H&E 
staining are indicating. 
Fig6. It is not clear what the arrow is used to 
indicate other than re-iterating increased ex-
pression
Discussion
This section is concise and the author attempts 
to draw conclusions from the results and relate 
it to a real-world application. He states “We 
have demonstrated the harmful effects of FA 
over-dosage (200µg-800µg) on blood cells.” 
This is likely reference to a prior study that is 
not referenced. If it is not published data, then 
it should be indicated as such. 
Future Directions
The author states:  “It has been suggested that 
FA is beneficial for cancer patients due to its 
cell proliferative properties.” After submis-
sion of this article, a new study has suggested 
otherwise in breast cancer. During revision, the 
author should look at this study as he plans 
future experiments – Manshandi et al.  PLOS 
One. 2014
Materials and Methods
Although mentioned in the body of the study, 
this section should mention the cell type 
used. The methods of the dot-blot assay are 
not described. The method of staining for cell 
morphology assessment should be described. 
Image-J software supplied should be refer-
enced. Antibodies used should be listed as this 
section should allow someone to replicate the 
study if desired.
Reviewer recommendation
Due to the need for major revisions to both the 
body of the article and the figures, I do not rec-
ommend this article be published in its current 
state. The author’s curiosity and interest in this 
type of work is commendable. Also commend-
able are the number of different techniques he 
attempted in this project.
